OMRF researchers found mutations in PDGF receptor beta can trigger two rare diseases.
cancer
OMRF researchers identify protein critical to healthy cell division
OMRF researchers discovered a protein critical to ensuring mitosis functions properly.
Military academy students get hands-on lab experience at OMRF
The Saxon program provides military academy students with an opportunity to work alongside OMRF senior scientists.
OMRF receives new grants to study blood clotting, ovarian cancer
The National Institutes of Health grants total nearly $2.1 million.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
OMRF researcher named to American Cancer Society Council
Jones has served the ACS for many years, both as a grant reviewer and speaker on the society’s behalf.
